We are live on ! Find out more
VIVO

Meridian Bioscience Inc
VIVO

Delisted

VIVO was delisted on the 30th of January, 2023.

Back to rankings

173 hedge funds and large institutions have $726M invested in Meridian Bioscience Inc in 2016 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 67 increasing their positions, 51 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 51

2% less capital invested

Capital invested by funds: $744M → $726M (-$17.9M)

4% less funds holding

Funds holding: 180 → 173 (-7)

39% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 18

60% less call options, than puts

Call options by funds: $655K | Put options by funds: $1.62M

Holders
173
Holders Change
-7
Holders Change %
-3.89%
% of All Funds
4.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
67
Reduced
51
Closed
18
Calls
$655K
Puts
$1.62M
Net Calls
-$967K
Net Calls Change
-$274K

Top Buyers

Rank Fund Capital Flow
1
PP
Prudential plc
United Kingdom
+$8.84M
2
BFA
BlackRock Fund Advisors
California
+$3.96M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$3.23M
4
Renaissance Technologies
Renaissance Technologies
New York
+$3.01M
5
AAM
ACK Asset Management
Connecticut
+$2.64M

Top Sellers

Rank Fund Capital Flow
1
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$10.1M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$8.99M
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$5.41M
4
EA
Emerald Acquisition
Washington
-$2.33M
5
GCP
GSA Capital Partners
United Kingdom
-$1.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of Montreal
151
Bank of Montreal
Ontario, Canada
$46K -$352 -18 -0.7%
MOACM
152
Mutual of America Capital Management
New York
$46K – – –
LTFS
153
Ladenburg Thalmann Financial Services
Florida
$43K +$1.64K +84 +4%
LIA
154
LS Investment Advisors
Michigan
$32K – – –
Zurich Cantonal Bank
155
Zurich Cantonal Bank
Switzerland
$28K +$6.03K +308 +27%
GT
156
Glenmede Trust
Pennsylvania
$23K – – –
IA
157
IFP Advisors
Florida
$22K -$450 -23 -2%
Fuller & Thaler Asset Management
158
Fuller & Thaler Asset Management
California
$20K +$20.5K +1,050 New
CG
159
Cutler Group
California
$17K – – –
SWA
160
Sutton Wealth Advisors
Florida
$14.2K – – –
SEI Investments
161
SEI Investments
Pennsylvania
$11K -$13.2K -675 -54%
BAM
162
Bruderman Asset Management
New York
$9K +$98 +5 +1%
VCM
163
Versant Capital Management
Arizona
$5K -$900 -46 -13%
FIB
164
First Interstate Bank
Montana
$4K – – –
PSC
165
Prentiss Smith & Co
Vermont
$4K – – –
AG
166
Advisor Group
Arizona
$3K +$1.08K +55 +50%
TCIM
167
TIAA CREF Investment Management
New York
$2.49K -$45K -2,300 -2%
Creative Planning
168
Creative Planning
Kansas
$2K +$1.6K +82 New
QCG
169
Quadrant Capital Group
Ohio
$1K – – –
TWA
170
TCI Wealth Advisors
Arizona
$1K – – –
VOYA Investment Management
171
VOYA Investment Management
Georgia
$412 – – –
Capital Fund Management (CFM)
172
Capital Fund Management (CFM)
France
– -$800K -41,000 Closed
ARTA
173
A.R.T. Advisors
New York
– -$609K -31,255 Closed
ACI
174
AMP Capital Investors
Australia
– -$411K -21,305 Closed
PAM
175
Princeton Alpha Management
New Jersey
– -$380K -19,482 Closed
4 5 6
7
8

VIVO Hedge Fund Activity: Q3 2016 in Review

173 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q3 2016, worth a combined $726M — down 2.4% from $744M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of VIVO and 11 opened new positions — a net loss of 7 holders — while 51 trimmed existing stakes and 67 added.

The largest buyer was Prudential plc, adding an estimated $8.84M. The largest seller was Schroder Investment Management Group, cutting an estimated $10.1M.

  • 173 institutional investors held Meridian Bioscience Inc (VIVO) as of Q3 2016, down from 180 in Q2 2016.
  • Funds reported $726M of Meridian Bioscience Inc stock for Q3 2016, down 2.4% quarter-over-quarter.
  • 11 funds opened new Meridian Bioscience Inc positions in Q3 2016 and 18 closed out, a net change of -7 holders.
  • The largest Meridian Bioscience Inc buyer in Q3 2016 was Prudential plc, an estimated $8.84M added.
  • The largest Meridian Bioscience Inc seller in Q3 2016 was Schroder Investment Management Group, an estimated $10.1M sold.

Based on aggregated 13F filings for Q3 2016.